The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Open accessAbstract
Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 has been previously identified as a key cytokine that directly induces tumuor growth in CRC via STAT3 activation in IECs.12,15,46,47.”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 577
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citation
Research works printed but not linked: 1
- Jerry, 1993, Cancer Res., 53, 3374
Cited by
Sorted by citations
Items 501–600 of 754
Han, W., Kong, D., Lu, Q., Zhang, W. J., & Fan, Z. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101706 · Cited by 13
He, X., Ao, Q., Wei, Y., & Song, J. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12427 · Cited by 14
New STAT3-FOXL2 pathway and its function in cancer cells
Han, Y., Wu, J., Yang, W., Wang, D., Zhang, T., & Cheng, M. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0206-3 · Cited by 13
Włodarczyk, M., Maryńczak, K., Burzyński, J., Włodarczyk, J., Basak, J., Fichna, J., Majsterek, I., Ciesielski, P., Spinelli, A., & Dziki, Ł. A. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01582-6 · Cited by 16
Marginean, E. C., Gotfrit, J., Marginean, H., Yokom, D. W., Bateman, J., Daneshmand, M., Sud, S., Gown, A. M., Jonker, D. J., Asmis, T. R., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100996 · Cited by 12
Liu, W., Geng, C., Li, X., Li, Y., Song, S., & Wang, C. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07805-0 · Cited by 12
Jang, Y. S., Kim, T. W., Ryu, J. S., Kong, H. J., Jang, S. H., Nam, G. H., Kim, J., & Jeon, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0277285 · Cited by 13
Song, L., Xu, R., Cai, W., Liang, J., Cao, N., Gao, J., & Tang, X. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13271 · Cited by 12
Ji, Y., Liu, B., Chen, L., Li, A., Shen, K., Su, R., Zhang, W., Zhu, Y., Wang, Q., & Xue, W. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00822-9 · Cited by 12
Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential
Lin, H., Li, J., Wang, M., Zhang, X., & Zhu, T. (2023) · Journal of Cancer · doi:10.7150/jca.84506 · Cited by 15
Liu, Y., Xi, Z., Zhou, J., Ling, F., Zhang, Y., Xie, H., Zheng, J., Xia, B., Feng, H., & Li, Y. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1342 · Cited by 12
Zhu, W., Long, J., Yin, Y., Guo, H., Jiang, E., Li, Y., He, Q., Zeng, C., & Sun, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7826 · Cited by 12
Qin, H., Wang, C., & Hua, Y. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.07.013 · Cited by 12
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00790-x · Cited by 12
Yu, Z., Chan, S., Wang, X., Sun, R., Wang, M., Wang, Z., Zuo, X., Chen, J., Zhang, H., & Chen, W. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s402824 · Cited by 12
RetractedThe Role of lncRNA-miR-26a-mRNA Network in Cancer Progression and Treatment
Zhu, J., & Wang, L. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10475-w · Cited by 12
Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
Bhavsar, C., Momin, M. M., Khan, T. A., & Omri, A. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1424825 · Cited by 13
The clinical impact of miRNA34a and P53 gene expression in colon cancer
Badr, E. A. E., Assar, M. F. A., Gohar, S. F., Badr, M., Hathout, R. M., & El-Kousy, S. M. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.10.002 · Cited by 12
Construction of an miRNA–mRNA regulatory network in colorectal cancer with bioinformatics methods
Su, Y., Zhang, M., Zhang, L., Chen, S., Zhang, D., & Zhang, X. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000745 · Cited by 12
Wang, C., Dou, C., Wang, Y., Liu, Z., Roberts, L. R., & Zheng, X. M. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33844 · Cited by 12
Li, C., Ci, Y., Liu, X., Chen, C., Liu, C., Li, X., Li, Q., & Song, Y. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1820055 · Cited by 12
The long-term tolerability of enalapril in hypertensive patients with renal impairment.
Keane, W. F., Polis, A., Wolf, D., Faison, E. P., & Shahinfar, S. (1997) · PubMed · Cited by 12
The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications
Hu, Z. H., Yuan, L., Yang, X., Yi, C., & Lu, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1332528 · Cited by 11
KLF4 Induces Colorectal Cancer by Promoting EMT via STAT3 Activation
Yuan, L., Meng, Y., & Xiang, J. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08473-y · Cited by 11
Wu, G., Hou, Q., Liu, Z., Pu, Z., & Wu, L. (2024) · Journal of Cancer · doi:10.7150/jca.97533 · Cited by 11
Amer, H., Kampan, N. C., Itsiopoulos, C., Flanagan, K. L., Scott, C. L., Kartikasari, A. E. R., & Plebanski, M. (2024) · Cancers · doi:10.3390/cancers16244187 · Cited by 12
Chen, X., Liu, S., Wang, H., Liu, Y., Xiao, Y., Li, K., Ni, F., Wu, W., Lin, H., Qing, X., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.013 · Cited by 13
Aquino, A., & Franzese, O. (2025) · Cancers · doi:10.3390/cancers17091547 · Cited by 13
Zhang, F., Wang, B., Qin, T., Wang, L., Zhang, Q., Lü, Y., Song, B., Yu, X., & Li, L. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03803-w · Cited by 11
Ji, N., & Yu, Z. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03694-x · Cited by 11
Xin, H., Deng, Y., & Cao, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.062 · Cited by 11
Bulvik, R., Biton, M., Berkman, N., Breuer, R., & Wallach‐Dayan, S. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062228 · Cited by 11
Liu, R., Choi, H. S., Ko, Y.-C., Yun, B., & Lee, D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119729 · Cited by 11
Analysis of the p53/microRNA Network in Cancer
Kaller, M., Hünten, S., Siemens, H., & Hermeking, H. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-08356-3_7 · Cited by 12
Self-citationLi, F., Zhang, Z., Cheng, T., Wei, R., Dai, Y., Lv, M., Luo, D., Zhu, X., Ma, D., Xi, L., et al. (2015) · Amino Acids · doi:10.1007/s00726-015-2060-8 · Cited by 11
Kim, S. J., García‐Recio, S., Creighton, C. J., Perou, C. M., & Rosen, J. M. (2019) · Oncogene · doi:10.1038/s41388-019-1017-x · Cited by 11
Alonso, V., Escudero, P., Fernández-Martos, C., Salud, A., Méndez, M., Gallego, J., Rodriguez, J.-R., Martín-Richard, M., Fernández-Plana, J., Manzano, H., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.004 · Cited by 10
miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer
Mei, Y., Li, K., Zhang, Z., Li, M., Yang, H., Wang, H., Huang, X., Li, X., Shi, S., & Yang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740452 · Cited by 10
“MicroRNAs (miRNAs) are a conserved class of small noncoding RNAs that have been recognized as key regulators of various cellular processes at post-transcriptional level (7, 8).”
BackgroundAdams, D. E., Zhen, Y., Qi, X., & Shao, W.-H. (2022) · Cells · doi:10.3390/cells11121869 · Cited by 10
Miguel, A. F. P., Poletto, A. G., Embaló, B., & Rivero, E. R. C. (2023) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2023.03.005 · Cited by 10
Nagaoka, Y., Oshiro, K., Yoshino, Y., Matsunaga, T., Endo, S., & Ikari, A. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109824 · Cited by 10
TL1A promotes metastasis and EMT process of colorectal cancer
Niu, W., Liu, Q., Huo, X., Luo, Y., & Zhang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24392 · Cited by 10
Zhang, Q., Jin, L., Jin, Q., Wei, Q., Sun, M., Yue, Q., Liu, H., Li, F., Li, H., Ren, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.727275 · Cited by 10
Self-citationCsf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a
Liu, F., Bouznad, N., Kaller, M., Shi, X., König, J., Jaeckel, S., & Hermeking, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75503 · Cited by 10
Self-citationGuo, Q., Zhou, W., Zhang, G.-B., Deng, Z.-F., Chen, X.-Z., Sun, F., Lei, X., Yan, Y., & Zhang, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16158 · Cited by 10
Su, Z., Hu, B., Li, J., Zeng, Z., Chen, H., Guo, Y., Mao, Y. J., & Cao, W. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12736 · Cited by 12
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT
Chen, T., Chou, C.-L., Tian, Y., Yeh, C.-F., Chan, T., He, H.-L., Li, W., Tsai, H.-H., Li, C., & Lai, H.-Y. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01944-6 · Cited by 10
Willems, A., Panchy, N. L., & Hong, T. (2023) · Cells · doi:10.3390/cells12020228 · Cited by 10
Signaling Pathways that Facilitate Chronic Inflammation-Induced Carcinogenesis
Hou, X., Yang, F., Liu, W., Fu, Z., Chen, L., Li, Z., Ni, C., Liu, M., & Cao, G. (2016) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000104 · Cited by 10
Song, K., Cai, H., Zheng, H., Yang, J., Jin, L., Xiao, H., Zhang, J., Zhao, Z., Li, X., Zhao, W., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab077 · Cited by 10
Chung, Y., Chen, S.-J., Chung, Y.-C., Liu, W., Lai, M., Kao, T., Yang, W., Yang, C., Hsu, C., & Chang, J. (2024) · Pharmaceuticals · doi:10.3390/ph17010127 · Cited by 9
Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events
dos Santos, T. W., Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16213621 · Cited by 10
Zeng, Y., Yin, Y., & Zhou, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313001 · Cited by 11
Li, Q., Chen, Y., Adeniran, S. O., Qiu, Z., Zhao, Q., & Zheng, P. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.07.013 · Cited by 9
Nemours, S., Armesto, M., Arestin, M., Manini, C., Giustetto, D., Sperga, M., Pivovarčíková, K., Pérez‐Montiel, D., Hes, O., Michal, M., et al. (2024) · Pathology · doi:10.1016/j.pathol.2023.11.013 · Cited by 9
The expanding regulatory universe of p53 in gastrointestinal cancer
Fesler, A. T., Zhang, N., & Ju, J. (2016) · F1000Research · doi:10.12688/f1000research.8363.1 · Cited by 9
Modeling ncRNA-Mediated Circuits in Cell Fate Decision
Tian, X., Ferro, M. V., & Goetz, H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8982-9_16 · Cited by 9
MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells
Wu, Y., Hu, L., Qin, Z., & Wang, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10098 · Cited by 9
MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma
Yokomizo, R., Yanaihara, N., Yamaguchi, N., Saito, M., Kawabata, A., Takahashi, K., Takenaka, M., Yamada, K., Shapiro, J. S., & Okamoto, A. (2019) · Oncotarget · doi:10.18632/oncotarget.27117 · Cited by 9
Gene Selection for the Discrimination of Colorectal Cancer
Wang, W., Xie, G., Ren, Z., Xie, T., & Li, J. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191119105209 · Cited by 9
Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer
Zhang, J., Zhang, H., Li, F., Song, Z., Li, Y., & Zhao, T. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00810-0 · Cited by 9
Meta-analysis of miR-34 target mRNAs using an integrative online application
Rokavec, M., Huang, Z., & Hermeking, H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.003 · Cited by 10
Self-citationPARs in the inflammation-cancer transformation of CRC
Lv, J., Liu, J., Chao, G., & Zhang, S. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03052-x · Cited by 9
The Molecular Basis of Metastatic Colorectal Cancer
Andres, S. F., Williams, K. N., & Rustgi, A. K. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0403-z · Cited by 10
Xiao, M., Zheng, Y., Wang, M., Sun, Y.-H., Chen, J., Zhu, K.-Y., Zhang, F., Tang, Y., Yang, F., Zhou, T., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01284-y · Cited by 8
Overview of research progress and application of experimental models of colorectal cancer
Li, L., Yan, Q., Chen, Z., Wei, X., Li, L., Tang, D., Tan, J., Xu, C., Yu, C., Lai, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1193213 · Cited by 12
New sights of immunometabolism and agent progress in colitis associated colorectal cancer
Zhang, J., Chen, C., Yan, W., & Fu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1303913 · Cited by 10
Du, H., You, L., Wu, A., Wang, F., Yu, J., & Chen, C. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01299-5 · Cited by 8
The role of MiRNA-34 family in different signaling pathways and its therapeutic options
Yahya, S. M. M., & Elsayed, G. H. (2024) · Gene · doi:10.1016/j.gene.2024.148829 · Cited by 8
Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
Sun, G., Wang, T., Shi, M., Zhou, H., Wang, J., Huang, Z., Zhang, H., & Shi, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-36 · Cited by 8
Park, H.-J., & Park, S. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1968444 · Cited by 8
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
Slabáková, E., Kahounová, Z., Procházková, J., & Souček, K. (2021) · Non-Coding RNA · doi:10.3390/ncrna7040075 · Cited by 9
The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer
Han, X., & Li, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113581 · Cited by 8
Epithelial-mesenchymal transition in gastroenterological cancer
Baba, H., Okabe, H., Mima, K., Saito, S., Hayashi, H., Imai, K., Nitta, H., Hashimoto, D., Chikamoto, A., Ishiko, T., et al. (2015) · Journal of Cancer Metastasis and Treatment · doi:10.4103/2394-4722.165118 · Cited by 8
Liu, Z., Wang, H., Guan, L., Chen, S., & Lai, M. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000605 · Cited by 8
Yang, L., Zhang, R., Yang, J., Bi, T., & Zhou, S. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s222555 · Cited by 8
Zhang, Y., Zhang, Y., Yao, S., Chen, L., Dong, Q., Luo, R., Zheng, K., Liu, J., Liu, Y., Chen, Y., et al. (2025) · Phytotherapy Research · doi:10.1002/ptr.70015 · Cited by 7
Khoshnazar, S. M., Salarizadeh, N., Mohammad-Sadeghipour, M., Shahpar, A., Izadi, M., Behzadnia, M. J., Khoozani, M. F., Alimohammadi, M., Farahani, N., & Hushmandi, K. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00677-9 · Cited by 8
Li, Y., Guo, G., Li, J., Fan, X., Li, T., Tong, L., Liu, P., Wang, X., Yuan, F., Yu, S., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.130 · Cited by 7
Xie, H., Zhang, Y., Tan, X., Zheng, Y., Ni, H., Dong, L., Zheng, J., Diao, J., Yin, Y., Zhang, J., et al. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0078 · Cited by 7
TGF-β and IL-6 family signalling crosstalk: an integrated model
Khatibi, S., Babon, J. J., Wagner, J., Manton, J. H., Tan, C. W., Zhu, H., Wormald, S., & Burgess, A. W. (2017) · Growth Factors · doi:10.1080/08977194.2017.1363746 · Cited by 7
Yang, C., & Deng, S. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.87274 · Cited by 7
Liu, Y., Yuan, J., Zhang, Q., Ren, Z., Li, G., & Tian, R. (2022) · Autoimmunity · doi:10.1080/08916934.2022.2037129 · Cited by 7
Feng, M., Wu, C., Zhang, H., Zhou, H., Jiao, T., Liu, M., & Sun, M.-J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i10.1949 · Cited by 7
Олегович, К. К., Safina, Е. R., Gaimakova, D. V., Frolova, Y. S., Oganesyan, I. Y., Sadertdinova, A. G., Александровна, Н. К., Islamgulov, A. K., Karimova, A. R., Galimova, A. M., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl13097 · Cited by 9
Zhang, L., Zhang, Y., Miao, M., Hu, S., Wang, X., Zhao, L., Huang, X., Cao, G., & Shou, D. (2022) · Bioengineered · doi:10.1080/21655979.2022.2085388 · Cited by 7
Araújo, R. L. C., da Fonseca, L. G., Silva, R. O., Linhares, M. M., & Usón, P. L. S. (2024) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-22-616 · Cited by 7
Li, S., Xu, X., & Li, Z. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.001 · Cited by 7
Yu, X., Pan, X., Zhang, S., Zhang, Y., Chen, L., Wan, S., Huang, T., & Cai, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.605012 · Cited by 7
Junaid, F., Tomić, G., Kemp, R., & Winton, D. J. (2023) · BMC Cancer · doi:10.1186/s12885-023-10581-3 · Cited by 6
Suleman, M., Khan, S. U., Ali, S., Alghamdi, A., Alissa, M., Mushtaq, R. Y., & Crovella, S. (2024) · Current Gene Therapy · doi:10.2174/0115665232336447241010094744 · Cited by 6
Chen, J., Wu, C., Yu, K., Liu, J., Yang, J., Li, W., Tang, X., Shi, Y., Xu, K., Chen, Y., et al. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06124-x · Cited by 6
NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA
Wang, C., He, X., Yan, G., & Liu, Z. (2023) · Oncology Reports · doi:10.3892/or.2023.8526 · Cited by 6
Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
Yan, S., Ma, C., Zhou, F., Zheng, H., Yang, L., Xiao, Z., Zhu, J., Zhao, H., Zhao, C., & Xu, X. (2023) · Journal of Cancer · doi:10.7150/jca.86544 · Cited by 6
Zhang, J., Li, C., Sun, L., Sun, D., & Zhao, T. (2023) · Oncology Reports · doi:10.3892/or.2023.8656 · Cited by 6
Lee, J. H., Ahn, E. H., Kwon, M. J., Ryu, C. S., Ha, Y. H., Ko, E. J., Lee, J. Y., Hwang, J. Y., Kim, J. H., Kim, Y. R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316794 · Cited by 6
Cloning of the promoter region of a human gene, FOXL2, and its regulation by STAT3
Han, Y., Wang, T., Sun, S., Zhai, Z., & Tang, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6914 · Cited by 5
Liu, L.-B., Liu, T., & Xin, F.-Z. (2017) · Medicine · doi:10.1097/md.0000000000007481 · Cited by 6
Stemness features in liver cancer
Correnti, M., Booijink, R. S., Maira, G. D., Raggi, C., & Marra, F. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.96 · Cited by 6
Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1.
Fan, J., Zhao, Y. F., Yuan, H., Yang, J., Li, T., He, Z., Wu, X., & Luo, C. (2020) · PubMed Central · Cited by 6
Metadata
- Authors
- Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., & Hermeking, H.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Universitätsmedizin Göttingen (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1853-1867
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3973098
- OpenAlex
- W2104268053
- Cited by
- 753
- References
- 66
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 60 · 2023: 66 · 2022: 90 · 2021: 69 · 2020: 66 · 2019: 76 · 2018: 59 · 2017: 69 · 2016: 65 · 2015: 66 · 2014: 20
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Johns Hopkins University (HCT116)
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Deutschen Konsortium für Translationale Krebsforschung
- FP7 Ideas: European Research Council (281967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- colorectal cancer, epithelial-mesenchymal transition, interleukin-6, IL-6 receptor, STAT3, miR-34a, feedback loops, tumor invasion, metastasis, p53, snails, microRNA regulation
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Female, Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Transcription Factors, Colorectal Neoplasms, Mice, Knockout, Receptors, Interleukin-6, Feedback, Physiological, MicroRNAs, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review